MHRA approves world's first lower-carbon beclometasone inhalers for patients with asthma

Contributed by: UK Government and Public Sector

Tags

Government

Inhaler

More Like This

Trixeo Aerosphere approved in the UK as first inhaled respiratory medicine using next-generation propellant with near-zero Global Warming Potential

Mundipharma and Vectura announce plans to reformulate flutiform® (fluticasone propionate/formoterol fumarate) pressurised metered-dose inhaler (pMDI) as a commitment to reducing the product’s carbon footprint

Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site

Chiesi Group ("Chiesi"), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today announced an expansion of their long-standing partnership, increasing pressurized metered dose inhaler (pMDI) manufacturing capacity at Bespak’s Holmes Chapel site to support the next phase of Chiesi’s Carbon Minimal Inhaler (CMI) program.

Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site

De Motu Cordis (DMC) announces plans for the next stage of development for DMC-IH1, an inhaled epinephrine drug device combination product

Lecanemab licensed for adult patients in the early stages of Alzheimer’s disease

Aptar Digital Health’s patient mobile app and HeroTracker® Sense sensor (Photo: Business Wire)

Aptar Digital Health Announces Asthma Clinical Study with Guy’s and St Thomas’ NHS Foundation Trust

Ocrelizumab approved as an injection to treat multiple sclerosis in adults